These results revealed a unique lethal regulation mediated by mitochondrial apoptosis, ER stress, and autophagy, providing potential insights into the development of novel therapeutic strategies involving the targeting of Bcl-2 families for GBM treatment. This evidence concerns the gene BCL2 and glioblastoma.